- Home
- BAX vs ELAN Comparison
BAX vs ELAN Comparison
Compare BAX & ELAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BAX | ELAN |
|---|---|---|
| Founded | 1931 | 1954 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 10.3B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | BAX | ELAN |
|---|---|---|
| Price | $20.75 | $24.85 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 10 |
| Target Price | $24.44 | $24.44 |
| AVG Volume (30 Days) | ★ 10.1M | 4.6M |
| Earning Date | 02-12-2026 | 02-24-2026 |
| Dividend Yield | ★ 0.20% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.07 |
| Revenue | ★ $11,244,000,000.00 | $4,591,000,000.00 |
| Revenue This Year | $1.50 | $7.25 |
| Revenue Next Year | $2.99 | $5.80 |
| P/E Ratio | ★ N/A | $354.90 |
| Revenue Growth | ★ 5.72 | 3.08 |
| 52 Week Low | $17.40 | $8.02 |
| 52 Week High | $37.74 | $26.08 |
Technical Indicators
Market Signals| Indicator | BAX | ELAN |
|---|---|---|
| Relative Strength Index (RSI) | 53.24 | 55.48 |
| Support Level | $18.58 | $24.76 |
| Resistance Level | $22.41 | $26.08 |
| Average True Range (ATR) | 0.81 | 0.71 |
| MACD | -0.07 | -0.03 |
| Stochastic Oscillator | 59.84 | 47.81 |
Price Performance
Historical ComparisonAbout BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
About ELAN Elanco Animal Health Incorporated
Elanco Animal Health is an animal health company that is engaged in developing, manufacturing, and marketing pharma products for companion and food animals. It spun off from Eli Lilly in 2018 and acquired Janssen Animal Health in 2011, Novartis Animal Health in 2014, Boehringer Ingelheim Vetmedica in 2017, and Bayer Animal Health in 2020. The company's operations are conducted globally, and it sells its products in over 90 countries. It offers a range of food animal products used in cattle, sheep, goats, and swine production.